MRI and PET/CT for triaging stage IB clinically operable cervical cancer to appropriate therapy: Decision analysis to assess patient outcomes

American Journal of Roentgenology

Volumn 192, Issue 3, 2009, Pages 802-814

  Pandharipande, Pari V ^a   Choy, Garry ^a   Del Carmen, Marcela G ^a   Gazelle, G Scott ^a   Russell, Anthony H ^a   Lee, Susanna I ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Cervical cancer; Decision analysis; Pelvic mri; PET CT

Indexed keywords

ARTICLE; CANCER STAGING; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PREVALENCE; PRIORITY JOURNAL; UTERINE CERVIX CANCER;

ALGORITHMS; DECISION SUPPORT TECHNIQUES; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; NEOPLASM STAGING; OUTCOME ASSESSMENT (HEALTH CARE); POSITRON-EMISSION TOMOGRAPHY; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED; TRIAGE; UTERINE CERVICAL NEOPLASMS;

EID: 63049136012     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/AJR.08.1224     Document Type: Article

References (30)

1. Lanciano R, Calkins A, Bundy BN, et al. Randomized comparison of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervix cancer: a gynecologic oncology group study. J Clin Oncol 2005; 23:8289-8295
2. Landoni F, Maneo A, Colombo A, et al. Randomised study of radical surgery versus radiotherapy for stage IB-IIA cervical cancer. Lancet 1997; 350:535-540
3. Hricak H, Gatsonis C, Chi DS, et al. Role of imaging in pretreatment evaluation of early invasive cervical cancer: results of the intergroup study American College of Radiology Imaging Network 6651-Gynecologic Oncology Group 183. J Clin Oncol 2005; 23:9329-9337
4. Hricak H, Gatsonis C, Coakley FV, et al. Early invasive cervical cancer: CT and MR imaging in preoperative evaluation-ACRIN/GOG comparative study of diagnostic performance and in- terobserver variability. Radiology 2007; 245: 491-498
5. Rotman M, Pajak TF, Choi K, et al. Prophylactic extended-field irradiation of para-aortic lymph nodes in stages IIB and bulky IB and IIA cervical carcinomas: ten-year treatment results of RTOG 79-20. JAMA 1995; 274:387-393
6. Russell AH. Truth and consequences. Gynecol Oncol 1999; 73:175-176
7. Sedlis A, Bundy BN, Rotman MZ, Lentz SS, Muderspach LI, Zaino RJ. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a Gynecologic Oncology Group Study. Gynecol Oncol 1999; 73:177-183
8. Sironi S, Buda A, Picchio M, et al. Lymph node metastasis in patients with clinical early-stage cervical cancer: detection with integrated FDG PET/CT. Radiology 2006; 238:272-279
9. Monk BJ, Wang J, Im S, et al. Rethinking the use of radiation and chemotherapy after radical hysterectomy: a clinical-pathologic analysis of a Gynecologic Oncology Group/Southwest Oncology Group/Radiation Therapy Oncology Group trial. Gynecol Oncol 2005; 96:721-728
10. Inoue T, Morita K. Long-term observation of patients treated by postoperative extended-field irradiation for nodal metastases from cervical carcinoma stages IB, IIA, and IIB. Gynecol Oncol 1995; 58:4-10
11. Peters WA 3rd, Liu PY, Barrett RJ 2nd, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high- risk early-stage cancer of the cervix. J Clin Oncol 2000; 18:1606-1613
12. Russell AH. Adjuvant postoperative radiation: what size target? Gynecol Oncol 1995; 58:1-3
13. National Comprehensive Cancer Network (NCCN) Website. NCCN clinical practice guidelines in oncology: cervical cancer, V.I. 2008. www.nccn.org/professionals.physician-gls/PDF/cervical.pdf. Accessed December 10, 2008
14. Barter JF, Soong SJ, Shingleton HM, Hatch KD, Orr JW Jr. Complications of combined radical hysterectomy-postoperative radiation therapy in women with early stage cervical cancer. Gynecol Oncol 1989; 32:292-296
15. Fiorica JV, Roberts WS, Greenberg H, Hoffman MS, LaPolla JP, Cavanagh D. Morbidity and survival patterns in patients after radical hysterectomy and postoperative adjuvant pelvic radiotherapy. Gynecol Oncol 1990; 36:343-347
16. James RM, Cruickshank ME, Siddiqui N. Management of cervical cancer: summary of SIGN guidelines. BMJ 2008; 336:41-43
17. Lagasse LD, Creasman WT, Shingleton HM, Ford JH, Blessing JA. Results and complications of operative staging in cervical cancer: experience of the Gynecologic Oncology Group. Gynecol Oncol 1980; 9:90-98
18. Russell AH, Shingleton HM, Jones WB, et al. Di agnostic assessments in patients with invasive cancer of the cervix: a national patterns of care study of the American College of Surgeons. Gynecol Oncol 1996; 63:159-165
19. Amendola MA, Hricak H, Mitchell DG, et al. Utilization of diagnostic studies in the pretreatment evaluation of invasive cervical cancer in the United States: results of intergroup protocol ACRIN 6651/GOG 183. J Clin Oncol 2005; 23:7454-7459
20. Choi HJ, Roh JW, Seo SS, et al. Comparison of the accuracy of magnetic resonance imaging and positron emission tomography/computed tomography in the presurgical detection of lymph node metastases in patients with uterine cervical carcinoma: a prospective study. Cancer 2006; 106: 914-922
21. Kim SH, Choi BI, Han JK, et al. Preoperative staging of uterine cervical carcinoma: comparison of CT and MRI in 99 patients. J Comput Assist Tomogr 1993; 17:633-640
22. Loft A, Berthelsen AK, Roed H, et al. The diagnostic value of PET/CT scanning in patients with cervical cancer: a prospective study. Gynecol Oncol 2007; 106:29-34
23. Subak LL, Hricak H, Powell CB, Azizi L, Stern JL. Cervical carcinoma: computed tomography and magnetic resonance imaging for preoperative staging. Obstet Gynecol 1995; 86:43-50
24. Shepherd JH. Cervical and vulva cancer: changes in FIGO definitions of staging. Br J Obstet Gynaecol 1996; 103:405-406
25. Inoue T, Okumura M. Prognostic significance of parametrial extension in patients with cervical carcinoma Stages IB, IIA, and IIB: a study of 628 cases treated by radical hysterectomy and lymph- adenectomy with or without postoperative irradiation. Cancer 1984; 54:1714-1719
26. Fuller AF Jr, Elliott N, Kosloff C, Hoskins WJ, Lewis JL Jr. Determinants of increased risk for recurrence in patients undergoing radical hysterectomy for stage IB and IIA carcinoma of the cervix. Gynecol Oncol 1989; 33:34-39
27. Uno T, Ito H, Isobe K, et al. Postoperative pelvic radiotherapy for cervical cancer patients with positive parametrial invasion. Gynecol Oncol 2005; 96:335-340
28. Zreik TG, Chambers JT, Chambers SK. Parame- trial involvement, regardless of nodal status: a poor prognostic factor for cervical cancer. Obstet Gynecol 1996; 87:741-746
29. Magrina JF, Goodrich MA, Weaver AL, Podratz KC. Modified radical hysterectomy: morbidity and mortality. Gynecol Oncol 1995; 59:277-282
30. Hunink MG, Glasziou P, Siegel JE, et al. Decision making in health and medicine. New York, NY: Cambridge University Press, 2001:128-153